Features differentiating comorbidity in elderly patients with Alzheimer-type dementia or with vascular dementia;Aspectos diferenciales de comorbilidad en pacientes ancianos con demencia tipo Alzheimer o con demencia vascular

Revista de Neurologia

Volumn 46, Issue 2, 2008, Pages 72-76

  Formiga, Francesc ^a   Fort, I ^b   Robles, M J ^c   Riu, S ^d   Rodriguez D ^e   Sabartes, O ^c  

^a L'Hospitalet de Llobregat   (Spain)

^b Alzheimer's Disease and Other Dementias Integral Care Unit   (Spain)

^c Del Mar University   (Spain)

^d Diputacio de Barcelona   (Spain)

^e Brain   (Spain)

Author keywords

Alzheimer's disease; Cognitive impairment; Comorbidity; Elderly; Polypharmacy; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; LAWTON INDEX; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; MULTIINFARCT DEMENTIA; MULTIVARIATE ANALYSIS; PRESCRIPTION; PROSPECTIVE STUDY; SCORING SYSTEM;

EID: 38949216786     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4602.2007490     Document Type: Article

References (36)

1. Vilalta-Franch J, López-Pousa S, Llinàs-Reglà J. Prevalencia de demencias en una zona rural. Estudio Girona. Rev Neurol 2000; 30: 1026-32.
2. García FJ, Sánchez MI, Pérez A, Martín E, Marsal C, Rodríguez G, et al. Prevalencia de demencia y de sus subtipos principales en sujetos mayores de 65 años: efecto de la educación y ocupación. Estudio Toledo. Med Clin (Barc) 2001; 116: 401-7.
3. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. Neurol Sci 2002; 203-204: 29-34.
4. Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CH, et al. Population-based study of medical comorbidity in early dementia and 'cognitive impairment, no dementia (CIND)': association with functional and cognitive impairment: the Cache County Study. Am J Geriatr Psychiatry 2005; 13: 656-64.
5. Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol Med Sci 2002; 87: M173-7.
6. Fu C, Chute DJ, Farga ES, Garakian J, Cummings JF, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med 2004; 128: 32-8.
7. Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK. Co-morbidity associated with dementia. Am J Alzheimer Dis Other Demen 2002; 17: 73-8.
8. Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 2006; 54: 104-9.
9. Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, et al. Clinical features associated with costs in early AD. Neurology 2006; 66: 1021-8.
10. Artaz MA, Boddaert J, Hériche-Taillandier E, Dieudonné B, Verny M, le group REAL.FR. Medical comorbidity in Alzheimer's disease: base-line characteristics of the REAL.FR Cohort. Rev Med Interne 2006; 27: 91-7.
11. Albert SM, Costa R, Merchant C, Small S, Jenders RA, Stern Y. Hospitalization and Alzheimer's disease: results from a community-based study. J Gerontol A Biol Sci Med Sci 1999; 54: M267-71.
12. Van Dijk PT, Dippel DW, Van Der Meulen JH, Habbema JD. Comorbidity and its effect on mortality in nursing home patients with dementia. J Nerv Ment Dis 1996; 184: 180-7.
13. Formiga F, Fort I, Robles MJ, Barranco E, Espinosa MC, Riu S. Comorbilidad en pacientes ancianos con demencia. Diferencias por edad y género. Rev Clin Esp 2007; 207: 495-500.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 ed. Washington DC: APA; 1993.
15. Mc Khann C, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
16. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, García JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
17. Reisberg B, Ferris SH, De Leon MJ, Crok T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-9.
18. Reisberg B. Functional Assessment Staging (FAST). Psychopharmacol Bull 1988; 24: 653-9.
19. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J 1965; 14: 61-5.
20. Cid-Rufaza J, Damián-Moreno J. Valoración de la discapacidad física: el índice de Barthel. Rev Esp Salud Publica 1997; 71: 127-37.
21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
22. Folstein MF, Folstein SE, McHugh PR. 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 1987; 40: 373-83.
24. Reig L, Formiga F, Robles MJ, Fort I, Espinosa MC, Rodríguez D. Fibrilación auricular en los pacientes ancianos con demencia. Rev Esp Geriatr Gerontol 2007; 42: 84.
25. Lyketsos CG, Sheppard JMES, Rabins PV. Dementia in elderly persons in the general hospital. Am J Psychiatry 2000; 157: 704-7.
26. McCormick WC, Kukull WA, Van Belle G, Bowen JD, Teri L, Larson EB. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994; 42: 517-21.
27. Ruitenberg A, Ott A, Van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001: 22: 575-80.
28. Gambassi G, Lapane KL, Landi F, Sgadari A, Mor V, Bernadie R. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Neurology 1999; 53: 508-16.
29. Erkinjunti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283-90.
30. Roman G, Wilkinson D, Doody R, Black S, Salloway S, Schindler RJ. Donepezil in vascular dementia: combined analysis of two large scale clinical trials. Dementia Geriatr Cogn Disord 2005; 20: 338-44.
31. Wilcock G, Möbius HJ, Stöffler A, MMM500 Group. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002; 17: 297-305.
32. Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007; 6: 782-92.
33. Robles-Bayón A. Acción de la memantina sobre la alteración cognitiva del paciente con demencia: reflexiones tras dos años de experiencia en España. Rev Neurol 2006; 42: 288-96.
34. Shiau MY, Yu L, Yuan HS, Lin JH, Liu CK. Functional performance of Alzheimer's disease and vascular dementia in Southern Taiwan. Kaohsiung J Med Sci 2006; 22: 437-46.
35. Groves WC, Brandt J, Steinberg M, Warren A, Rosenblatt A, Baker A, et al. Vascular dementia and Alzheimer disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000; 12: 305-15.
36. Álvarez-Saúco M, Moltó-Jordà JM, Morera-Guitart J, Frutos-Alegría MT, Matías-Guiu J. Actualización en el diagnóstico de la demencia vascular. Rev Neurol 2005; 41: 484-92.